NV-Clindamycin 25 mg Capsule is a Health Canada–registered veterinary drug (DIN 02245830) held by Teva Canada Limited, containing Clindamycin (Clindamycin Hydrochloride). Health Canada lists its status as Dormant (status date 24 Jul 2018). Nexara Health has matched 825 registrations of Clindamycin (Clindamycin Hydrochloride) across 32 other regulated markets, 2 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02245830 |
|---|---|
| Brand name | NV-Clindamycin |
| Active ingredient | Clindamycin (Clindamycin Hydrochloride) |
| Strength | 25 mg |
| Dosage form | Capsule |
| Route | Oral |
| Company | Teva Canada Limited |
| Status | Dormant — 24 Jul 2018 |
| Class | Veterinary |
| ATC | |
| AHFS | 92:24.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Clindamycin (Clindamycin Hydrochloride) registered in other markets
825 registrations of the same molecule in 32 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 25 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Clinacin Vet. | Chanelle Pharmaceuticals Manufacturing Limited | 25 mg | kapsler, hårde | MRP | Laegemiddelstyrelsen |
| Argentina | Clidan | Cassarß | gel dérm.x 15 g | Listed | PAMI | |
| Argentina | Clidan 300 | Cassarß | cáps. x 16 | Listed | PAMI | |
| Argentina | Clindacin | Panalab | sol.x 50 ml | Listed | PAMI | |
| Argentina | Clindacin | Panalab | gel x 50 g | Listed | PAMI | |
| Argentina | Clindalaf | Lafedar | 300 mg cáps.x 16 | Listed | PAMI | |
| Argentina | Clindamicina Fabra | Fabra | 600 mg a.x 1 | Listed | PAMI | |
| Argentina | Clindamicina Richet | Richet | 300 mg cáps.x 16 | Listed | PAMI | |
| Argentina | Clintopic | Siegfried | loc.x 30 ml | Listed | PAMI | |
| Australia | Clindamyk | Af | Capsule 150 mg (as hydrochloride) | GE | PBS | |
| Australia | Dalacin C | Pf | Capsule 150 mg (as hydrochloride) | GE | PBS | |
| Austria | Clienzo 10 mg/g + 50 mg/g Gel | — | 30g | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 300 mg Kaps. | — | 16St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | — | 12St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | — | 30St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | — | 12St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | — | 30St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindamycin "1A Pharma" 300 mg Kaps. | — | 16St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindamycin "1A Pharma" 450 mg Filmtabl. | — | 12St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Avocin | Middle East Pharmaceutical Industries Co. Ltd (Avalon Pharma), Ksa. | 2 %W/W | Vaginal Cream | POM | NHRA |
| Bahrain | Avocin | Middle East Pharmaceutical Industries Co. Ltd (Avalon Pharma), Ksa. | 1 %W/V | Topical Solution | POM | NHRA |
| Bahrain | Clindacin | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 300 MG | Capsule | POM | NHRA |
| Bahrain | Clindacin | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 150 MG | Capsule | POM | NHRA |
| Bahrain | Clindacin | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 1 % W/W | Gel | POM | NHRA |
| Bahrain | Clindacin T | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 10 MG/ML | Cutaneous Solution | POM | NHRA |
| Bahrain | Dalacin | Pfizer Inc, Usa. | 100 MG | Ovules | POM | NHRA |
| Bahrain | Dalacin-C | Pfizer Holding France, France. | 150 MG | Capsule | POM | NHRA |
| Bolivia | Clindamicina | — | 75 mg/5 ml | Suspensión o Jarabe | R | LINAME (formulary) |
| Bolivia | Clindamicina | — | 300 mg | Comprimido | R | LINAME (formulary) |
| Bolivia | Clindamicina | — | 600 mg | Inyectable | LINAME (formulary) | |
| Bulgaria | Clindamycin ABR | Антибиотик - Разград АД | 300 mg capsules, hard | капсула, твърда | По лекарско предписание | BDA |
| Bulgaria | Clindamycin ABR | Антибиотик - Разград АД | 150mg capsules, hard | капсула, твърда | По лекарско предписание | BDA |
| Bulgaria | Clindamycin ABR | Антибиотик - Разград АД | 600 mg capsules, hard | капсула, твърда | По лекарско предписание | BDA |
| Bulgaria | Clindamycin Kabi | Fresenius Kabi d.o.o. | 150 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Clindamycin-MIP | MIP Pharma GmbH | 300 mg film - coated tablets | филмирани таблетки | По лекарско предписание | BDA |
| Bulgaria | Clindamycin-MIP | MIP Pharma GmbH | 600 mg film - coated tablets | филмирани таблетки | По лекарско предписание | BDA |
| Bulgaria | Clindamycin-MIP | MIP Pharma GmbH | 150 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Clindavasin D | Антибиотик - Разград АД | 10 mg/g cutaneous solution - 30ml | разтвор за кожа | По лекарско предписание | BDA |
| Czech Republic | Clindamycin Hameln | — | 150MG/ML | Inj/Inf Sol | R | SUKL DLP |
| Czech Republic | Clindamycin Kabi | — | 150MG/ML | Inj Sol/Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Clindamycin Noridem | — | 150MG/ML | Inj/Inf Sol | R | SUKL DLP |
| Czech Republic | Dalacin | — | 20MG/G | Vag Crm | R | SUKL DLP |
| Czech Republic | Dalacin C | — | 150MG | Cps Dur | R | SUKL DLP |
| Czech Republic | Dalacin C | — | 300MG | Cps Dur | R | SUKL DLP |
| Czech Republic | Dalacin C | — | 150MG/ML | Inj/Inf Sol | R | SUKL DLP |
| Czech Republic | Duac | GlaxoSmithKline, s.r.o. | 10MG/G+50MG/G | Gel | B | SUKL DLP |
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 150 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 300 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 75 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Clinacin Vet. | Chanelle Pharmaceuticals Manufacturing Limited | 75 mg | kapsler, hårde | MRP | Laegemiddelstyrelsen |
| Denmark | Clinacin Vet. | Chanelle Pharmaceuticals Manufacturing Limited | 150 mg | tabletter | MRP | Laegemiddelstyrelsen |
| Denmark | Clinacin Vet. | Chanelle Pharmaceuticals Manufacturing Limited | 75 mg | tabletter | MRP | Laegemiddelstyrelsen |
| Dominican Republic | Clavel | Laboratorios Cymacla, S.r.l. | Registered | MISPAS | ||
| Dominican Republic | Clidets | Stiefel Mexicana,S.a De C.v, De Mexico | Registered | MISPAS | ||
| Dominican Republic | Clinda D 300 | Laboratorios Ameripharma, S.r.l | Registered | MISPAS | ||
| Dominican Republic | Clinda D 600 mg | Laboratorios Ameripharma, S.r.l | Registered | MISPAS | ||
| Dominican Republic | Clindabiotic® 300 | Grob Pharma Corp | Registered | MISPAS | ||
| Dominican Republic | Clindacin 1% | Panalab S.a., Argentina | Registered | MISPAS | ||
| Dominican Republic | Clindamicina | Laboratorio San Luis, S.a | Registered | MISPAS | ||
| Dominican Republic | Clindamicina | M/S East African (India) Overseas | Registered | MISPAS | ||
| Ecuador | CLINDAMICINA 100 mg ÓVULOS | Kronos Laboratorios C. Ltda | CLINDAMICINA FOSFATO 118 mg (EQUIVALENTE A 100 mg DE CLINDAMICINA) | Óvulos | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 100mg + Ketoconazol 400mg Óvulos Inpharchem | Farmayala Pharmaceutical Company S.a. Fpc | Clindamicina 100mg Ketoconazol 400mg | Ovulos Vaginales | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 150 mg/ mL Solución Inyectable | Caplin Point Laboratories Ltd. | 150 mg/mL | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 150 mg/mL | Hiral Labs Limited | Clindamicina fosfato equivalente a Clindamicina.................................150 mg | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Ecuador | CLINDAMICINA 150 mg/mL | Pharmabrand S.a. | Clindamicina 600.00 mg/ 4 mL | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Ecuador | CLINDAMICINA 300 mg CÁPSULAS | Caplin Point Laboratories Ltd. | CLINDAMICINA 300 mg | Capsulas | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 300 mg. Capsulas | Genfar S.a. | Clindamicina Clorhidrato USP 78% B.H....................................... 384.62000 mg equivalente a Clindamicina base ............................................... 300.00000 mg | Capsulas | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 300mg Tabletas Recubiertas Inpharchem | Farmayala Pharmaceutical Company S.a. | Clindamicina 300mg | Tabletas Recubiertas | VIGENTE | ARCSA registro sanitario |
| Greece | ACNATAC GEL.EXT.US (10+0.25) MG/G TUBx30 g | Viatris Healthcare Limited, Ireland | reimbursed | MoH deltio timwn | ||
| Greece | Cleo-Fort® Vag.sup 100mg/Supp Bt X 3 Σε Ταινια Απο Pvc/Pe | Nassington Ltd, Cyprus | reimbursed | MoH deltio timwn | ||
| Greece | CLIDACIN® BA FREE INJ.SO.INF 300MG/2ML AMP BTx1 AMPx2 ML | Βιανεξ Α.ε. Ανωνυμος Εμποροβιομηχανικη-Τουριστικη-Ξενοδοχειακη Και Ναυτιλιακη Ανωνυμος Εταιρεια Δ.τ. Βιανεξ Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | CLIDACIN® BA FREE INJ.SO.INF 600MG/4ML AMP BTx1AMPx4ML | Βιανεξ Α.ε. Ανωνυμος Εμποροβιομηχανικη-Τουριστικη-Ξενοδοχειακη Και Ναυτιλιακη Ανωνυμος Εταιρεια Δ.τ. Βιανεξ Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | Climycen Vag.cr 2% Tubx40g+7appl. | Help Α.β.ε.ε. Ανωνυμη Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Και Νοσοκομειακων Ειδων Δ.τ. Help Α.β.ε.ε./Help S.a. , Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 2ml | Ανφαρμ Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 4ml | Ανφαρμ Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 10 Amps (Glass-Type I) X 2ml | Ανφαρμ Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Iceland | Antirobe vet | Icepharma - óskráð | 150 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Antirobe vet | Icepharma - óskráð | 300 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Antirobe vet | Icepharma - óskráð | 75 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Antirobe vet | Icepharma - óskráð | 25 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Clindamycin EQL Pharma | EQL Pharma AB | 150 mg | hylki | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Clindamycin EQL Pharma | EQL Pharma AB | 300 mg | hylki | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Dalacin | Parlogis - óskráð lyf | 15 mg/ml | mixt.kyr | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Dalacin | Pfizer ApS | 300 mg | hylki | 1 | Lyfjastofnun lyfjaverdskra |
| Ireland | Clindamycin 150 mg Capsules, hard | Renata Pharmaceuticals (Ireland) Limited | Capsule, hard | Marketed | HPRA | |
| Ireland | Clindamycin 150 mg/ml solution for injection | Fresenius Kabi Deutschland GmbH | Solution for injection | Marketed | HPRA | |
| Ireland | Clindamycin 150 mg/ml solution for injection/infusion | AS Kalceks | Solution for injection/infusion | Not marketed | HPRA | |
| Ireland | Clindamycin 150 mg/ml Solution for injection/infusion | Noridem Enterprises Limited | Solution for injection/infusion | Not marketed | HPRA | |
| Ireland | Clindamycin 300 mg Capsules | EG (Eurogenerics) | Capsule, hard | Marketed | HPRA | |
| Ireland | Clindamycin 300 mg Capsules, hard | Renata Pharmaceuticals (Ireland) Limited | Capsule, hard | Not marketed | HPRA | |
| Ireland | Clindamycin 75 mg Capsules, hard | Renata Pharmaceuticals (Ireland) Limited | Capsule, hard | Not marketed | HPRA | |
| Ireland | Dalacin 100 mg Vaginal Ovule | Pfizer Healthcare Ireland Unlimited Company | Pessary | Not marketed | HPRA | |
| Italy | CLINDAMICINA FOSFATO*5 fiale 600 mg 4 ml | HIKMA ITALIA SpA | CLINDAMICINA 600MG 5 UNITA' USO PARENTERALE | Classe A | AIFA liste A/H | |
| Italy | CLINDAMICINA FOSFATO*5 fiale IM EV 600 mg 4 ml | BIOINDUSTRIA L.I.M. SpA | CLINDAMICINA 600MG 4ML 5 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | DALACIN C FOSFATO*1 fiala IM EV 600 mg 4 ml | PFIZER ITALIA Srl | CLINDAMICINA 600MG 1 UNITA' USO PARENTERALE | Classe A | AIFA liste A/H | |
| Italy | DALACIN C*12 cps 150 mg | PFIZER ITALIA Srl | CLINDAMICINA 150MG 12 UNITA' USO ORALE | Classe A | AIFA liste A/H | |
| Jordan | Clindacid-T 1% | Al-Gadeed Pharmaceutical Industries/JORDAN | 10 MG/1 ML | Topical solution | NEW APPLICATION | JFDA drug registrations |
| Lebanon | Clindamycin | Pharmadex | 100mg | Vaginal ovules | A1 | MoPH |
| Luxembourg | CLINDAMYCINE EG GELUL. 300 mg 1*16 GELUL.SS BLIST. | — | RR | CNS liste positive | ||
| Luxembourg | CLINDAMYCINE EG GELUL. 300 mg 1*32 GELUL.SS BLIST. | — | RR | CNS liste positive | ||
| Luxembourg | Clindamycine EG GELUL. 600 mg 1*16 gélules ss blist. | — | RR | CNS liste positive | ||
| Luxembourg | Clindamycine EG GELUL. 600 mg 1*32 gélules ss blist. | — | RR | CNS liste positive | ||
| Luxembourg | Dalacin C GELUL. 150 mg 1*16 gelul. | — | RR | CNS liste positive | ||
| Luxembourg | Dalacin C GELUL. 300 mg 1*16 gélules ss blist. | — | RR | CNS liste positive | ||
| Luxembourg | Dalacin Vaginal CR. 2 PC 1*1 tube 40 g | — | RR | CNS liste positive | ||
| Luxembourg | Treclinax GEL 10 mg / 1 g + 0,25 mg / 1 g 1*1 tube 30 g | — | RR | CNS liste positive | ||
| Malaysia | Axcel Clindamycin Topical Solution 1% W/V | Kotra Pharma (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Clinacin 150 mg Tablets For Dogs | Rhone Ma Malaysia Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Clinacin 25 mg Tablets For Dogs | Rhone Ma Malaysia Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Clinacin 75 mg Tablets For Dogs | Rhone Ma Malaysia Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Dalacin C Capsule 150mg | Pfizer (Malaysia) Sdn. Bhd. | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malaysia | Dalacin C Capsules 300mg | Pfizer (Malaysia) Sdn. Bhd. | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malaysia | Dalacin C Phosphate Sterile Solution 150mg/mL (2ml Amp) | Pfizer (Malaysia) Sdn. Bhd. | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malaysia | Klindam Capsule 150mg | Prime Pharmaceutical Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malta | Dalacin 150 mg hard capsules | JV Healthcare Limited | Hard Capsule | Authorised | Medicines Authority | |
| Malta | DALACIN C 150 mg hard capsules | Pharma Regulatory Services Limited | Hard Capsule | Authorised | Medicines Authority | |
| Malta | DALACIN C 300 mg hard capsules | Pfizer Hellas S.A. | Hard Capsule | Withdrawn | Medicines Authority | |
| Malta | DALACIN C 300 mg hard capsules | NM Pharma Limited | Hard Capsule | Authorised | Medicines Authority | |
| Malta | Dalacin C 300mg Hard Capsules | NeoFarma Pharmaceuticals Limited | Hard Capsule | Authorised | Medicines Authority |
See every manufacturer of Clindamycin (Clindamycin Hydrochloride) worldwide →
Regulator price references for Clindamycin (Clindamycin Hydrochloride)
Published list or reimbursement prices for Clindamycin (Clindamycin Hydrochloride) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Clindamycin LU | Capsule 150 mg (as hydrochloride) | 4.00 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Dalacin C | Capsule 150 mg (as hydrochloride) | 4.00 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Dalacin C 150 mg Kaps. | 150mg | 16St | 6.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Dalacin Vaginalcreme | 20000mg | 20g | 8.75 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 600 mg Filmtabl. | 600mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 450 mg Filmtabl. | 450mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | 450mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | 600mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin-MIP 300 mg Filmtabl. | 300mg | 16St | 10.45 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Dalacin C 300 mg Kaps. | 300mg | 16St | 10.45 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin-MIP 600 mg Filmtabl. | 600mg | 16St | 13.30 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 300 mg Kaps. | 300mg | 16St | 13.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 300 mg Kaps. | 300mg | 16St | 13.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clienzo 10 mg/g + 50 mg/g Gel | 30000mg | 30g | 15.80 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 450 mg Filmtabl. | 450mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 600 mg Filmtabl. | 600mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | 450mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | 600mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin-MIP 600 mg Filmtabl. | 600mg | 32St | 21.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Avocin | 30ML | 1.43 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Dalacin-C | 300mg/2ml | 2ML | 1.43 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Medacin T | 1pct | 30ML | 1.47 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Clindacin | 150mg | 16 | 1.52 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Derma-T | 30ML | 1.63 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Clindacin | 1pct | 30G | 1.78 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dalacin-C | 150mg | 16 | 1.78 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Clindacin | 300mg | 16 | 2.49 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Qcin | 150mg | 24 | 2.65 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Clindacin T | 10mg/1ml | 50ML | 2.73 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dalacin-C | 300mg | 16 | 3.23 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Qcin | 300mg | 30 | 4.03 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Avocin | 40G | 6.11 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Dalacin | 100mg | 3 | 7.07 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Yenlip | 100mg | 7 | 10.69 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 2ml | 150mg/1ml | 0.66 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLIDACIN® BA FREE INJ.SO.INF 300MG/2ML AMP BTx1 AMPx2 ML | 300mg/2ml | 0.68 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLINDAMYCIN/TARGET CUT.SOL 1% FLx30ML | 1pct+30ml | 1.32 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Demo So.inj.inf 150mg/mL Bt X 1 Φυσιγγα Χ 4ml | 150mg/1ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 4ml | 150mg/1ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VELDOM INJ.SO.INF 150MG/1ML BTx1AMPx4ML (600MG) | 150mg/1ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | EDASON INJ.SOL 600MG/4ML AMP BTx1 AMP x 4 ML | 600mg/4ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLIDACIN® BA FREE INJ.SO.INF 600MG/4ML AMP BTx1AMPx4ML | 600mg/4ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TOLIKEN CUT.SOL 1% (W/V) FLx30 ML | 1pct+30ml | 1.61 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | YGIELLE CUT.SOL 1% W/V FL x 30 ML | 1pct+30ml | 1.61 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C INJ.SOL 600MG/4ML AMP BTx1AMPx4ML | 600mg/4ml | 2.04 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C GEL.EXT.US 1% (W/W) TUBx30G | 1pct+30000mg | 3.10 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C CAPS 300MG/CAP ΒΤx16(BLIST 2x8) | 300mg | 3.22 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ESTERIA VAG.CR 2% W/W BT x 1 TUB x 40 G+ 7 δοσιμετρικοί εφαρμοστές 7 δοσιμετρικοί εφαρμοστές | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Fouch Vag.cr 2% Tubx40g+7 Appl | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | YGIELLE VAG.CR 2% W/W TBx40 G+7 APPL. | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Velkaderm Vag.cr 2% Tubx40g+7appl | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VELDOM VAG.CR 2% W/W BT x TUB x 40G+7 δοσομετρικοί εφαρμοστές δοσομετρικοί εφαρμοστές | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | UPDERM VAG.CR 2% (W/W) TUBx40 G+7 Δοσιμετρικοί εφαρμοστές Δοσιμετρικοί εφαρμοστές | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VAGICLIN VAG.CR 2% W/W TUBx40G+7APPL | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Climycen Vag.cr 2% Tubx40g+7appl. | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLINDAMYCIN/COOPER INJ.SO.INF 600MG/4ML BTx5 amp x4ML | 600mg/4ml | 6.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 10 Amps (Glass-Type I) X 2ml | 150mg/1ml | 6.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Demo So.inj.inf 150mg/mL Bt X 5 Φυσιγγες Χ 4ml | 150mg/1ml | 6.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C VAG.CR 2% (W/W) TUB x 40G (7 δοσομετρικοί εφαρμοστές) (7 δοσομετρικοί εφαρμοστές) | 2pct+40000mg | 7.02 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Cleo-Fort® Vag.sup 100mg/Supp Bt X 3 Σε Ταινια Απο Pvc/Pe | 100mg | 7.69 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLINDAMYCIN/KABI INJ.SOL 150MG/ML BT x 5 AMPS x 4 ML | 150mg/1ml | 8.11 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | YENLIP VAG.SUP 100MG/SUP BTx7 (1 STRIP x7 SUP) | 100mg | 10.45 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | INDOXYL GEL.EXT.US (1+5)% W/W TUB x 30 G | 30000mg | 11.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ACNATAC GEL.EXT.US (10+0.25) MG/G TUBx30 g | 30000mg | 12.90 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | INDOXYL GEL.EXT.US (1+3)% W/W 1 TUB x 30g (σωληνάριο Glaminate) | 30000mg | 12.90 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 10 Amps (Glass-Type I) X 4ml | 150mg/1ml | 13.26 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TRETICLIN GEL.EXT.US (1+0.025)% w/w BTx1 TUBx50G | 50000mg | 16.22 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | INDOXYL GEL.EXT.US (1+5)% W/W TUB x 60 G | 60000mg | 21.17 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Dalacin | 150mg/1ml | lykja | 763.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 150mg/1ml | lykja | 1,398.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Clindamycin EQL Pharma | 150mg | þpakki | 1,500.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 20mg/1000mg | sett | 1,598.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 300mg | þpakki | 1,689.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 10mg/1ml | glas | 1,844.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Clindamycin EQL Pharma | 300mg | þpakki | 2,011.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Duac | 60mg/1000mg | túpa | 3,236.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| United Arab Emirates | Derma-T ® | 1000mg/100ml | 30ml Bottle + Applicator | 22.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | DALACIN C ™ 300mg | 300mg | 16's (8's Blister x 2) | 33.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Medacin T | 10mg/1000mg | 30g Collapsible Tube | 39.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Dalacin ® Vaginal Ovule | 100mg | 3's Strip | 77.00 AED | public | EDE | 2026-08-31 |
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02436914 | Auro-Clindamycin | Auro Pharma Inc | 300 mg | Capsule |
| 02436906 | Auro-Clindamycin | Auro Pharma Inc | 150 mg | Capsule |
| 02400537 | Clindamycin | Sanis Health Inc | 300 mg | Capsule |
| 02400529 | Clindamycin | Sanis Health Inc | 150 mg | Capsule |
| 02230535 | Clindamycin Injection USP | Sandoz Canada Incorporated | 150 mg | Solution |
| 02230540 | Clindamycin Injection USP | Sandoz Canada Incorporated | 150 mg | Liquid |
| 02462664 | Med-Clindamycin | Generic Medical Partners Inc | 300 mg | Capsule |
| 02462656 | Med-Clindamycin | Generic Medical Partners Inc | 150 mg | Capsule |
| 02493756 | Nra-Clindamycin | Nora Pharma Inc | 300 mg | Capsule |
| 02493748 | Nra-Clindamycin | Nora Pharma Inc | 150 mg | Capsule |
| 02468484 | Riva-Clindamycin | Laboratoire Riva Inc. | 300 mg | Capsule |
| 02266938 | Taro-Clindamycin | Taro Pharmaceuticals Inc | 1 % | Solution |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is NV-Clindamycin (DIN 02245830) marketed in Canada?
No. Health Canada lists DIN 02245830 as Dormant as of 24 Jul 2018.
Who holds the Canadian licence for this product?
Teva Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Clindamycin (Clindamycin Hydrochloride) registered outside Canada?
Yes — Nexara Health has matched 825 registrations in 32 other markets, including 2 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02245830, status date 2018-07-24; national medicine registries: AIFA liste A/H, ARCSA registro sanitario, BDA, CNS liste positive, eEKO (Erstattungskodex), HPRA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NPRA, PAMI, PBS, SUKL DLP; price sources: EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02245830, status date 2018-07-24; national medicine registries: AIFA liste A/H, ARCSA registro sanitario, BDA, CNS liste positive, eEKO (Erstattungskodex), HPRA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NPRA, PAMI, PBS, SUKL DLP; price sources: EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS.
Teva Canada Limited — company profileWho else makes Clindamycin (Clindamycin Hydrochloride)All Canadian Clindamycin (Clindamycin Hydrochloride) productsAuro-ClindamycinAuro-ClindamycinClindamycinClindamycinClindamycin Injection USP
Health Canada Drug Product Database (DPD), DIN 02245830, status date 2018-07-24; national medicine registries: AIFA liste A/H, ARCSA registro sanitario, BDA, CNS liste positive, eEKO (Erstattungskodex), HPRA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NPRA, PAMI, PBS, SUKL DLP; price sources: EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.